All doses of the diabetes and weight management injectable tirzepatide (Mounjaro, Zepbound) were taken off the FDA's shortage ...

With an estimated 2 million people in the United States taking copycat vers | A compounding industry group has sued the FDA, ...

A trade organization representing compounding pharmacies that make unbranded versions of the weight loss drugs Mounjaro and ...

Now that Mounjaro has been authorised for use on the NHS, it will be key that access to specialist weight loss services is ...

The Outsourcing Facilities Association (OFA) has filed a lawsuit against the U.S. Food and Drug Administration (FDA) regarding the agency’s sudden removal of Tirzepatide, a GLP-1 medication used to ...

FDA faces legal action after removing Tirzepatide from the shortage list without following required procedures, sparking ...

A group representing makers of compounded drugs sued FDA over its decision to call an end to the shortage of Lilly's (LLY) ...

Tirzepatide for diabetes vs long-acting insulins demonstrated superior glycemic control and weight loss compared among adults with type 2 diabetes.

McDonald's is suing major meatpackers for allegedly colluding to inflate beef prices by limiting supplies since 2015. PepsiCo ...

Dumb Blonde” podcast host Bunnie XO said she’s already lost more than a pound — but said she's “microdosing” tirzepatide ...

On October 2, 2024, the U.S. Food and Drug Administration (FDA) determined the shortage of the tirzepatide injection, a glucagon-like peptide ...

Tirzepatide injection (Zepbound, Mounjaro) is officially off the FDA's drug shortage list, meaning compounders can no longer prepare and dispense the drug.